Impact of Vitamin D on Gut Microbiome and Metabolome Among Pediatric Oncology Patients
Key facts
- Who runs it
- Children's Hospital of Orange County
- Where
- Orange, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 9 Nov 2026
- Expected to end
- 31 Dec 2027
- Type of study
- Observational
- Record updated
- 16 November 2026
Who can take part
- Age
- 0 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Ages 0-18 years
- Newly diagnosed with acute lymphoblastic leukemia, including B-cell ALL, T-cell ALL, mixed phenotype actue leukemia (MPAL), and Philadelphia-positive or Philadelphia-like ALL
Who cannot take part
- Diagnosed with other malignancies, congenital gastrointestinal or bowel diseases, or inflammatory bowel diseases
- Hypersensitivity to vitamin D
- Pregnant
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 0 and 18 years old?
This trial is currently available in United States.
- Children's Hospital of Orange CountyOrange, United StatesContact: Kathryn Duvall, MSN RN CCRP CPONTaking people
About the trial
What the trial wants to find out
Brief Summary The purpose of this observational study is to better understand how vitamin D levels affect the gut microbiome (the bacteria that live in the intestines) in children who are newly diagnosed with acute lymphoblastic leukemia (ALL). Researchers want to learn whether low vitamin D levels are linked to changes in gut bacteria and whether this may affect how children with ALL respond to chemotherapy.
Read full original descriptionShow less
The main questions this study aims to answer are:
* Are the gut bacteria different in children with ALL who have low vitamin D levels compared to those with normal vitamin D levels at the time of diagnosis? * How do vitamin D levels relate to changes in gut bacteria and related body processes before and after induction chemotherapy? Researchers will compare children who have low vitamin D levels with those who have normal vitamin D levels to see if there are differences in their gut bacteria and how those bacteria change during early treatment. The stool samples will be studied in specialized laboratories to better understand how vitamin D and gut bacteria interact.
The results of this study may help doctors understand whether monitoring and managing vitamin D levels could improve care and treatment outcomes for children with ALL.
Participants will:
Have four study visits:
* Screening: Review and sign consent/assent forms, review of Inclusion/Exclusion Criteria, medical history, and current medications * At diagnosis (baseline): Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection * Day 29-32 - At the end of induction chemotherapy: Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection and Adverse event assessment * Day 90-97 after Induction: Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection and Adverse event assessment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07938333, who can take part
- Record updated
- 16 November 2026